• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Introduction to (3-chloro-7-isoquinolyl)boronic Acid (CAS No. 2096331-38-1)

(3-chloro-7-isoquinolyl)boronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. With the CAS number 2096331-38-1, this compound represents a unique structural motif that combines the versatility of boronic acids with the pharmacophoric potential of isoquinoline derivatives. Boronic acids are well-known for their role as key intermediates in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic organic chemistry. The presence of the chloro and isoquinolyl substituents in this molecule endows it with distinct chemical and biological properties, making it a valuable building block for the development of novel therapeutic agents and advanced materials.

The isoquinoline scaffold is a prominent heterocyclic system that has been extensively explored in medicinal chemistry due to its broad spectrum of biological activities. Isoquinolines and their derivatives are known to exhibit properties such as antimicrobial, anti-inflammatory, anticancer, and antiviral effects. The incorporation of a chloro group at the 3-position of the isoquinoline ring enhances its reactivity and functionalization potential, opening up avenues for further derivatization and structural optimization.

Boronic acids, on the other hand, are renowned for their ability to form stable complexes with diols, a property that has been leveraged in various applications including drug delivery systems and diagnostic probes. The boronic acid functional group in (3-chloro-7-isoquinolyl)boronic acid allows for its participation in cross-coupling reactions, enabling the construction of complex molecular architectures with high precision. This characteristic makes it an indispensable tool in the synthesis of biologically active compounds and functional materials.

Recent advancements in the field have highlighted the potential of (3-chloro-7-isoquinolyl)boronic acid in the development of targeted therapies. For instance, studies have demonstrated its utility in generating novel boron-containing drugs that exhibit enhanced selectivity and reduced toxicity compared to traditional chemotherapeutic agents. The isoquinolyl moiety, in particular, has been shown to improve binding affinity to biological targets such as enzymes and receptors, thereby increasing the efficacy of drug candidates.

In addition to its pharmaceutical applications, this compound has shown promise in materials science. The unique electronic properties of boronic acids have been exploited to design organic semiconductors and luminescent materials. The presence of the chloro group and the rigid isoquinoline ring contribute to steric and electronic effects that can be fine-tuned to achieve desired material properties. This has led to innovative applications in optoelectronics, where (3-chloro-7-isoquinolyl)boronic acid derivatives have been used to fabricate light-emitting diodes (LEDs) and organic photovoltaic cells.

The synthesis of (3-chloro-7-isoquinolyl)boronic acid involves multi-step organic transformations that require precise control over reaction conditions. Typically, it begins with the functionalization of an isoquinoline precursor followed by the introduction of a boronic acid moiety. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to achieve high yields and purity. The chloro substituent plays a crucial role in these reactions, often serving as a handle for further modifications through nucleophilic substitution or metalation strategies.

Ongoing research continues to uncover new applications for this compound. For example, recent studies have explored its potential as a chiral ligand in asymmetric synthesis, where its ability to induce high enantioselectivity has been harnessed to produce chiral drugs with improved pharmacological profiles. Furthermore, the compound's stability under various conditions makes it suitable for industrial-scale production, ensuring its accessibility for both academic and commercial applications.

The versatility of (3-chloro-7-isoquinolyl)boronic acid is further underscored by its compatibility with green chemistry principles. Efforts have been made to develop synthetic routes that minimize waste and utilize sustainable solvents, aligning with global initiatives aimed at reducing environmental impact. These innovations not only enhance the sustainability of pharmaceutical manufacturing but also contribute to cost-effective production processes.

In conclusion, (3-chloro-7-isoquinolyl)boronic acid (CAS No. 2096331-38-1) is a multifaceted compound with significant implications across multiple scientific disciplines. Its unique structural features enable diverse applications ranging from drug development to advanced materials design. As research progresses, we can expect even more innovative uses for this compound, further solidifying its importance in modern chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)